SCHEMBL22904091

SCHEMBL22904091

Cc1cccc(CC(=O)N2CCC3(CC2)CC(=O)NC(=O)C3)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.64
CHRM2 P08172 1/20 0.48
CHRM3 P20309 1/20 0.48
RECQL P46063 1/20 0.47
GABRD O14764 1/20 0.47
GABRA1 P14867 1/20 0.47
GABRB1 P18505 1/20 0.47
GABRA5 P31644 1/20 0.47
GABRA3 P34903 1/20 0.47
GABRA2 P47869 1/20 0.47
GABRB2 P47870 1/20 0.47
GABRA4 P48169 1/20 0.47
OPRD1 P41143 1/20 0.46
OPRK1 P41145 1/20 0.46
ALDH1A1 P00352 2/20 0.45
HTT P42858 1/20 0.45
CASP3 P42574 1/20 0.43
CASP7 P55210 1/20 0.43
ORAI1 Q96D31 2/20 0.43
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14238826 0.81 POLB (0.88) POLBRECQLALDH1A1HTTCASP3
SCHEMBL10196666 0.79 POLB (1.00) POLBRECQLALDH1A1HTTMAPT
SCHEMBL14543129 0.79 POLB (0.94) POLBRECQLALDH1A1HTTCASP3
SCHEMBL22904402 0.79 GABRD (0.70) CHRM2CHRM3GABRDGABRA1GABRB1
SCHEMBL14238825 0.77 POLB (0.97) POLBRECQLALDH1A1HTTMAPT
SCHEMBL14238824 0.77 POLB (0.97) POLBRECQLALDH1A1HTTMAPT
SCHEMBL4548029 0.76 POLB (0.78) POLBRECQLALDH1A1HTTMAPT
SCHEMBL10196663 0.75 POLB (0.76) POLBRECQLALDH1A1HTTMAPT
SCHEMBL19710624 0.74 POLB (0.74) POLBRECQLOPRD1OPRK1ALDH1A1
SCHEMBL16578039 0.74 POLB (0.74) POLBRECQLALDH1A1HTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021011631-A1 FUSED-GLUTARIMIDE CRBN LIGANDS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2021-01-21 WO disclosed